Ara
Toplam kayıt 472, listelenen: 461-470
Response to the article by González HP et al entitled “Ex vivo dermoscopy in demodicosis”
(Elsevier Inc., 2023)
Letter to editor
Polymer-mediated nanoformulations: a promising strategy for cancer immunotherapy
(Springer Science and Business Media Deutschland GmbH, 2023)
Engineering polymer-based nano-systems have attracted many researchers owing to their unique qualities like shape, size, porosity, mechanical strength, biocompatibility, and biodegradability. Both natural and synthetic ...
Letter to the Editor: “Concurrent multi-session anodal trans-cranial direct current stimulation enhances pelvic floor muscle training effectiveness for female patients with multiple sclerosis suffering from urinary incontinence and pelvic floor dysfunction: a randomized clinical trial study”
(Institute for Ionics, 2023)
Letter to editor
How useful are the H2FPEF and HFA-PEFF scoring algorithms in the diagnosis of heart failure with preserved ejection fraction?
(Taylor and Francis Ltd., 2023)
Letter to editor
Postoperative Pain Management Challenge
(Elsevier Inc., 2023)
Letter to editor
Can D-dimer be a diagnostic saviour in patients with acute aortic dissection?
(Taylor and Francis Ltd, 2023)
Letter to editor
Letter to the editor: “Validation and predictive capacity of a Dutch version of the FLARE‐RA questionnaire within the context of a TNFi‐tapering trial”
(Springer Science and Business Media Deutschland GmbH, 2023)
Letter to editor
Prognostic value of lactate/albumin ratio in patients with acute-on-chronic liver failure
(Elsevier Ltd, 2023)
Letter to editor
Meeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicine
(MDPI, 2023)
In recent decades, nanotechnology has been rapidly advancing in various fields of human activity, including veterinary medicine. The review presents up-to-date information on recent advancements in nanotechnology in the ...
Letter to the Editor: “Translation and validation of Cerebral Palsy Quality of Life Questionnaire‐Teen in Hong Kong Chinese population [CP QoL‐Teen (HK)]”
(Springer Science and Business Media Deutschland GmbH, 2023)
Letter to editor